[BACK]

Presentations

• Fluzone vaccine is licensed for use in children 6 months of age and older
  
  
• All presentations of Fluzone vaccine are latex free
  
  
• Fluzone^®, Influenza Virus Vaccine, No Preservative: Pediatric Dose (children 6 through 35 months of age)
  
  • Specially labeled and packaged for pediatric dosing
    
  
  
• Fluzone^®, Influenza Virus Vaccine, No Preservative (children 36 months and up)
  
  
• Fluzone vaccine multi-dose vials
  
  

View full Prescribing Information for Fluzone vaccine. [MORE]

Indication
Fluzone vaccine is given for active immunization in persons 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

Safety Information
Side effects to Fluzone vaccine are soreness, pain, and swelling at the injection site; fever, fatigue, and muscular pain. Other side effects may occur. Fluzone vaccine should not be administered to anyone with a history of serious allergic reaction to any vaccine component, including eggs, egg products, or thimerosal (the only Fluzone vaccine product containing thimerosal is the multi-dose vial), or to persons who have been previously diagnosed with Guillain-Barré syndrome (GBS). If you notice any other problems or symptoms following vaccination, please contact your health-care professional immediately. Vaccination with Fluzone vaccine may not protect all individuals.
 
For more information about Fluzone vaccine, talk to your health-care professional.

Last modified: 11/16/09

[BACK]